Semler Scientific, Inc. (SMLR)

Semler Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	57.33	23.01	37.32	22.08	7.74
Short-Term Investments	0	20.07	0	0	0
Cash & Cash Equivalents	57.33	43.09	37.32	22.08	7.74
Cash Growth	33.06%	15.44%	69.04%	185.22%	135.72%
Receivables	6.13	3.88	3.62	2.81	3.49
Inventory	0.45	0.47	0.55	0.34	0
Other Current Assets	2.04	1.47	4.04	1.38	0.22
Total Current Assets	65.94	48.91	45.54	26.6	11.44
Property, Plant & Equipment	0.72	0.67	0.39	0.26	0.25
Long-Term Investments	5.88	5.5	0.82	3.05	0
Other Long-Term Assets	5.52	7.62	3.92	4.72	6.6
Total Long-Term Assets	12.12	13.79	5.14	8.04	6.84
Total Assets	78.07	62.69	50.67	34.64	18.29
Accounts Payable	0.4	0.84	0.44	0.68	0.34
Deferred Revenue	1.12	1.16	0.92	0.96	0.96
Other Current Liabilities	4.68	4.86	3.52	2.87	3.91
Total Current Liabilities	6.2	6.86	4.88	4.51	5.21
Other Long-Term Liabilities	0.07	0.16	0.25	0.33	0.01
Total Long-Term Liabilities	0.07	0.16	0.25	0.33	0.01
Total Liabilities	6.27	7.02	5.13	4.85	5.21
Retained Earnings	59.8	39.22	24.9	7.67	-6.33
Shareholders' Equity	71.8	55.68	45.55	29.79	13.07
Net Cash / Debt	57.33	43.09	37.32	22.08	7.74
Net Cash / Debt Growth	33.06%	15.44%	69.04%	185.22%	135.72%
Net Cash Per Share	7.33	5.39	4.59	2.74	0.96
Working Capital	59.74	42.05	40.66	22.09	6.24
Book Value Per Share	10.66	8.28	6.77	4.53	2.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).